FailedFiled Feb 25, 2026
Sponsor: Justin Brown (R)
Latest Action
Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee
May 7, 2026
Summary
The bill moves xylazine, a drug currently used in animal medicine, into Missouri’s Schedule III list of controlled substances. It allows the drug to be manufactured or administered to animals, but restricts any other use to the same rules that apply to Schedule III drugs. This change aims to curb the growing misuse of xylazine in illicit drug markets while preserving legitimate veterinary applications.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when SB 1724 changes status, plus AI-powered summaries and stage predictions.
Sign up free